Aligos Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Aligos Therapeutics

07/11/2024 14:16

* Aligos Therapeutics Inc  ALGS.OQ  reported a quarterly
adjusted
loss of $3.07​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-10.25.  The mean expectation of three analysts
for the quarter was for a loss of $2.16 per share. Wall Street
expected results to range from $-4.40 to 45 cents per share.
    * Revenue fell 60.8% to $1.27 million from a year ago;
analysts
expected $333.33 thousand. 
    * Aligos Therapeutics Inc's reported EPS for the quarter was
a
loss of $3.07​.
    * The company reported a quarterly loss of $19.26 million.
    * Aligos Therapeutics Inc shares had risen by 8.0% this
quarter and lost 43.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 115.7% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aligos
Therapeutics Inc is $75.00 
This summary was machine generated from LSEG data November 7 at
02:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -2.16          -3.07          Missed
 Jun. 30 2024      -4.00          0.80           Beat
 Mar. 31 2024      -4.75          -5.50          Missed
 Dec. 31 2023      -6.75          -5.50          Beat